Publikationen

2015

Brenner W, Haber T, Junker K, Roos F, Thüroff JW. (2015) Bone metastasis by renal cell carcinoma. Importance of calcium and calcium-sensing receptor. Urologe A; 54(6):839-43.

Haber T, Jöckel E, Roos FC, Junker K, Prawitt D, Hampel C, Thüroff JW, Brenner W; German Renal Cell Tumor Network (2015). Bone Metastasis in Renal Cell Carcinoma is Preprogrammed in the Primary Tumor and Caused by AKT and Integrin α5 Signaling. J Urol. 194(2):539-46

2014

Steffens* S, Junker* K, Roos* FC, Janssen* M, Becker F, Henn D, Wegener G, Siemer S, Hofmann R, Schrader M, Stöckle M, Thüroff JW, Hartmann A, Kuczyk MA, Schrader AJ; German Renal Tumor Network (2014). Small renal cell carcinomas - How dangerous are they really? Results of a large multicenter study. Eur J Cancer 50(4):739-45 * equally contributed

Joeckel E, Haber T, Prawitt D, Junker K, Hampel C, Thüroff JW, Roos FC, Brenner W (2014). High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor. Mol Cancer. 13:42

Roos* FC, Steffens* S, Junker K*, Janssen* M, Becker F, Wegener G, Brenner W, Steinestel J, Schnoeller TJ, Schrader M, Hofmann R, Thüroff JW, Kuczyk MA, Wunderlich H, Siemer S, Hartmann A, Stöckle M, Schrader AJ (2014). Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinoma. BMC Cancer 14(1):372 * equally contributed

Steffens S*, Roos FC*, Janssen M*, Becker F, Steinestel J, Abbas M, Steinestel K, Wegener G, Siemer S, Thüroff JW, Hofmann R, Stöckle M, Schrader M, Hartmann A, Junker K, Kuczyk MA, Schrader AJ; For the German Renal Cell Cancer Network (2014). Clinical behavior of chromophobe renal cell carcinoma is less aggressive than that of clear cell renal cell carcinoma, independent of Fuhrman grade or tumor size. Virchows Arch. 465(4):439-44 * equally contributed

Steffens S*, Janssen M*, Roos FC*, Becker F, Steinestel J, Abbas M, Steinestel K, Wegener G, Siemer S, Thüroff JW, Hofmann R, Stöckle M, Schrader M, Hartmann A, Hasenfus A, Kuczyk MA, Junker K, Schrader AJ; German Renal Cell Cancer Network (2014). The Fuhrman grading system has no prognostic value in patients with nonsarcomatoid chromophobe renal cell carcinoma. Hum Pathol. 45(12):2411-6 * equally contributed

2013

Steffens S, Ringe KI, Schroeer K, Lehmann R, Rustemeier J, Wegener G, Schrader M, Hofmann R, Kuczyk MA, Schrader AJ; German Renal Cell Tumor Network. Does overweight influence the prognosis of renal cell carcinoma? Results of a multicenter study. Int J Urol. 2013, 20(6):585-92.

Becker F*, Junker K*, Parr M, Hartmann A, Füssel S, Toma M, Grobholz R, Pflugmann T, Wullich B, Strauss A, Behnes CL, Otto W, Stöckle M, Jung V (2013). Collecting duct carcinomas represent a unique tumor entity based on genetic alterations. PLoS One; 22;8(10):e78137 * equally contributed  

2012

Junker K. Foundation of the german network renal cell tumors association. Urologe A. 2012, 51(4):555-6.

Steffens S, Janssen M, Roos FC, Becker F, Schumacher S, Seidel C, Wegener G, Thüroff JW, Hofmann R, Stöckle M, Siemer S,

Schrader M, Hartmann A, Kuczyk MA, Junker K, Schrader AJ. Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma--a multicentre study. Eur J Cancer. 2012, 48(15):2347-52

Steffens S, Köhler A, Rudolph R, Eggers H, Seidel C, Janssen M, Wegener G, Schrader M, Kuczyk MA, Schrader AJ. Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients. BMC Cancer. 2012, 12:399

2011

Waalkes S, Roos FC, Eggers H, Schumacher S, Janssen M, Wegener G, Thüroff JW, Hofmann R, Schrader M, Kuczyk MA, Schrader AJ; Deutsches Netzwerk Nierenzelltumoren. Incidence and long-term prognosis of papillary renal cancer. Results of a retrospective multicenter study. Urologe A. 2011, 50(9):1125-9

Waalkes S, Eggers H, Rustemeier J, Wegener G, Jentzmik F, Schrader M, Hofmann R, Kuczyk MA, Schrader AJ; Für das deutsche Netzwerk Nierenzelltumoren. Overweight is an advantageous prognostic marker in patients with clear cell kidney cancer. Urologe A. 2011, 50(9):1118-24

Waalkes S, Becker F, Schrader AJ, Janssen M, Wegener G, Merseburger AS, Schrader M, Hofmann R, Stöckle M, Kuczyk MA. Is there a need to further subclassify pT2 renal cell cancers as implemented by the revised 7th TNM version? Eur Urol. 2011; 59(2):258-63

Steffens S, Grünwald V, Ringe KI, Seidel C, Eggers H, Schrader M, Wacker F, Kuczyk MA, Schrader AJ. Does obesity influence the prognosis of metastatic renal cell carcinoma in patients treated with vascular endothelial growth factor-targeted therapy? Oncologist. 2011, 16(11):1565-71 

2008

2007

Mitgliederbereich

Bitte melden Sie sich an